Nerve Decompression Surgery for Diabetic Peripheral Neuropathy: The Dellon Procedure

Quick answer: Nerve Decompression Surgery Diabetic Peripheral Neuropathy Dellon is a common foot/ankle topic that affects many patients. The 2026 evidence-based approach combines proper diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Hills practices. Call (810) 206-1402.

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

✅ Medically Reviewed by Dr. Tom Biernacki, DPM — Board-certified podiatrist at Balance Foot & Ankle, Southeast Michigan. Last updated April 2026.

Table of Contents

• The Concept Behind Nerve Decompression
• The Double Crush Hypothesis
• Patient Selection Criteria
• Compression Sites in the Lower Extremity
• The Dellon Surgical Procedure
• Recovery and Expected Timeline
• Published Outcomes and Evidence
• Risks and Limitations
• Post-Surgical Recovery Products
• Most Common Mistake
• Warning Signs
• Video Guide
• FAQ
• Sources
• Book an Appointment

Disclosure: This page contains affiliate links. As an Amazon Associate, I earn from qualifying purchases. These are products I personally recommend to my patients — your purchase supports this free educational resource at no additional cost to you.

The Concept Behind Peripheral Nerve Decompression

Peripheral nerve decompression for diabetic neuropathy is based on the principle that diabetes makes nerves more vulnerable to compression at anatomical sites where they pass through tight tunnels or beneath rigid structures. Just as carpal tunnel syndrome compresses the median nerve at the wrist in non-diabetic patients, the tibial nerve and its branches can become compressed at the tarsal tunnel and other fibro-osseous tunnels in the ankle and foot. In a healthy person, these tunnels accommodate the nerves comfortably. In a diabetic patient, metabolic changes cause nerve swelling (increased endoneurial edema) that makes the nerves too large for their existing tunnels, creating compression that compounds the metabolic nerve damage already caused by diabetes.

Dr. A. Lee Dellon, a plastic surgeon and peripheral nerve specialist at Johns Hopkins, developed the hypothesis that surgically releasing these compression points could restore nerve function in diabetic patients — not by treating the diabetes-related metabolic nerve damage, but by eliminating the superimposed mechanical compression that makes symptoms significantly worse. The surgery does not cure diabetic neuropathy. Rather, it removes one of the two factors (metabolic damage plus mechanical compression) contributing to nerve dysfunction, potentially allowing the nerve to function at a higher level than it would with both insults present simultaneously.

The Double Crush Hypothesis in Diabetic Neuropathy

The theoretical foundation for nerve decompression surgery rests on the “double crush” hypothesis, originally described by Upton and McComas in 1973. This concept proposes that a nerve damaged at one level becomes more susceptible to compression at another level. In diabetic neuropathy, the first “crush” is the systemic metabolic damage caused by chronic hyperglycemia — glucose-mediated oxidative stress, accumulation of sorbitol via the polyol pathway, and advanced glycation end-products that directly damage nerve fibers throughout the body.

The second “crush” occurs at specific anatomical sites where the metabolically compromised nerve passes through tight tunnels. The tibial nerve at the tarsal tunnel, the common peroneal nerve at the fibular head, and the deep peroneal nerve at the anterior tarsal tunnel are the primary compression sites in the lower extremity. Because the diabetic nerve is already swollen from metabolic edema and has reduced tolerance for additional insult, it develops compressive symptoms at pressure levels that would be well-tolerated by a healthy nerve. Decompression surgery targets this second crush — the mechanical component — which is the surgically addressable portion of the problem.

Patient Selection: Who Benefits from Nerve Decompression

Patient selection is the single most important factor determining outcomes from nerve decompression surgery for diabetic neuropathy. The ideal candidate has symptomatic diabetic peripheral neuropathy (numbness, tingling, burning pain in the feet) with a positive Tinel’s sign at one or more known compression sites — meaning that tapping over the nerve tunnel reproduces or worsens the patient’s symptoms. A positive Tinel’s sign suggests that the nerve is viable enough to generate a signal when mechanically stimulated, indicating that decompression may allow improved function. Patients with completely absent nerve responses on electrodiagnostic testing may have irreversible nerve damage beyond what decompression can address.

Additional selection criteria include documented neuropathy on nerve conduction studies or quantitative sensory testing, adequate blood supply to the lower extremity (ABI above 0.7), no active foot ulceration, and the ability to comply with postoperative restrictions. Patients with reasonable glucose control (HbA1c ideally below 9%) tend to have better outcomes because their metabolic environment supports nerve recovery after the mechanical compression is relieved. The procedure is not appropriate for all diabetic neuropathy patients — those without identifiable compression points, those with purely small-fiber neuropathy (which is not compression-related), or those with severe peripheral vascular disease are generally not candidates.

Compression Sites in the Lower Extremity

The Dellon approach targets four primary nerve compression sites in the lower extremity. The tarsal tunnel — located behind the medial malleolus (inner ankle bone) — is the most common and most important site. Here, the tibial nerve and its branches (medial plantar, lateral plantar, and calcaneal nerves) pass beneath the flexor retinaculum (laciniate ligament) along with tendons and blood vessels. In diabetic patients, nerve swelling within this rigid tunnel creates compression similar to carpal tunnel syndrome. Surgical release involves dividing the flexor retinaculum and freeing the nerve branches within the tunnel.

The common peroneal nerve at the fibular head (outside of the knee) is the second compression site. This nerve wraps around the bony prominence of the fibular head beneath a fibrous arch, making it vulnerable to compression — especially in diabetic patients who cross their legs frequently or have lost the protective subcutaneous fat in this area. The deep peroneal nerve at the anterior tarsal tunnel (top of the foot beneath the inferior extensor retinaculum) is the third site, and the superficial peroneal nerve where it exits the lateral compartment of the leg is the fourth. A comprehensive decompression procedure may address all four sites in a single operative session or prioritize specific sites based on clinical and electrodiagnostic findings.

The Dellon Surgical Procedure

The Dellon nerve decompression procedure is performed under regional or general anesthesia, typically as an outpatient surgery. For tarsal tunnel decompression — the most common component — the surgeon makes an incision behind the medial malleolus following the course of the tibial nerve. The flexor retinaculum is carefully divided, and the tibial nerve is identified and traced distally as it divides into its three terminal branches: the medial plantar nerve, lateral plantar nerve, and calcaneal nerve. Each branch is followed through its individual tunnel, releasing any fibrous bands, tight fascial edges, or accessory muscles that create compression along its course.

The procedure requires careful surgical technique because the nerves in diabetic patients are often more fragile and adherent to surrounding structures than in non-diabetic patients. Internal neurolysis — carefully freeing the nerve from adhesions within the tunnel — may be performed when the nerve appears constricted by scarring. For peroneal nerve decompression at the fibular head, a separate incision is made laterally and the fibrous arch compressing the nerve is released. The entire multi-site procedure typically takes 60-90 minutes per leg. Both legs may be addressed simultaneously or staged several weeks apart depending on surgeon preference and patient factors.

Recovery and Expected Timeline

Recovery from nerve decompression surgery follows a gradual timeline because nerve regeneration is inherently slow — peripheral nerves regenerate at a rate of approximately 1 millimeter per day, or roughly 1 inch per month. Immediate postoperative management includes a protective boot or splint, limited weight-bearing for 2-3 weeks, and wound care. Most patients can return to light activities by 3-4 weeks and regular footwear by 6 weeks. However, the functional nerve recovery that patients are most interested in — improved sensation, reduced pain, better balance — unfolds over months to years.

Pain improvement is often the first benefit noticed, sometimes within the first few weeks as the mechanical compression on the nerve is relieved. Tingling and paresthesias (abnormal sensations) may initially increase after surgery as the nerve begins to recover — this is actually a positive sign indicating nerve regeneration, though it can be discouraging if patients are not forewarned. Meaningful sensory return typically begins at 3-6 months and may continue improving for up to 18-24 months postoperatively. Balance improvement, which depends on proprioceptive nerve fiber recovery, follows a similar extended timeline. Setting realistic expectations about this gradual recovery is essential for patient satisfaction.

Published Outcomes and Evidence

The evidence supporting nerve decompression for diabetic neuropathy is encouraging but not without controversy. Dr. Dellon’s published series report improvement in pain and sensation in approximately 80-90% of properly selected patients, with some studies showing restoration of protective sensation that may reduce ulcer and amputation risk. A landmark study by Nickerson demonstrated that patients undergoing nerve decompression had a significantly lower incidence of foot ulcers and amputations compared to a matched non-surgical control group over a 4.5-year follow-up period.

Critics point out that most of the supporting evidence comes from case series and retrospective studies rather than large randomized controlled trials — the gold standard in medical evidence. A 2019 Cochrane review concluded that while available evidence is suggestive of benefit, the quality of evidence is insufficient to make definitive recommendations. However, proponents argue that the ethical challenges of randomizing symptomatic patients to sham surgery make traditional RCTs difficult to conduct, and that the accumulated case series data across multiple surgical groups worldwide represents a meaningful body of evidence. Ongoing prospective studies may provide the higher-quality data needed to resolve this debate definitively.

Risks and Limitations

As with any surgical procedure, nerve decompression carries risks. Wound healing complications are a primary concern in diabetic patients — the same vascular compromise and immune dysfunction that contributes to foot ulcers also impairs surgical wound healing. Infection rates are slightly higher than in non-diabetic populations. Nerve injury during surgery — though rare in experienced hands — can potentially worsen symptoms. Scar tissue formation around the decompressed nerve may cause recurrent compression in some patients, particularly those with poorly controlled diabetes where ongoing metabolic damage continues to cause nerve swelling.

The most significant limitation is that nerve decompression does not address the underlying metabolic nerve damage caused by diabetes. If glucose control remains poor after surgery, ongoing metabolic insult will continue to damage nerve fibers regardless of how successfully the mechanical compression was relieved. Patients must understand that surgery is one component of a comprehensive neuropathy management strategy that must include glucose optimization, nutritional support, regular monitoring, and consistent foot protection. Surgery without metabolic management is likely to provide only temporary benefit as progressive neuropathy eventually overwhelms the advantage gained from decompression.

Supporting Recovery After Nerve Decompression

Recovery from nerve decompression surgery benefits from products that address post-surgical biomechanical needs, inflammation control, and circulation support during the extended nerve regeneration period.

PowerStep Orthotic Insoles for Post-Decompression Support

As sensation gradually returns after nerve decompression, the recovering foot needs consistent biomechanical support to prevent the overuse injuries that can occur when patients resume activities they had avoided due to neuropathic pain. PowerStep Pinnacle orthotic insoles provide structured arch support and pressure redistribution that protects the foot during the transition from surgical recovery to full activity. The semi-rigid arch support is particularly important for neuropathy patients because it compensates for the weakened intrinsic foot muscles that result from motor nerve damage — even as sensory function improves, motor recovery may lag behind.

For diabetic neuropathy patients specifically, PowerStep insoles serve a dual protective role: they redistribute plantar pressure away from vulnerable metatarsal heads (where most diabetic ulcers develop) and provide the consistent foot alignment that reduces mechanical stress on the recovering nerves. As the decompressed nerves regenerate, abnormal mechanical loading can irritate the healing nerve tissue, potentially prolonging recovery. Quality orthotic support minimizes this mechanical irritation while simultaneously protecting against the ulceration risk that persists throughout the neuropathy recovery period.

Doctor Hoy’s Natural Pain Relief for Neuropathic Discomfort

The post-decompression recovery period often includes a phase of increased tingling, burning, or hypersensitivity as nerve fibers regenerate — a phenomenon called “reinnervation dysesthesia” that can be distressing despite being a positive prognostic sign. Doctor Hoy’s Natural Pain Relief Gel provides topical relief using menthol and arnica that can modulate these uncomfortable sensations without the systemic side effects of oral neuropathic pain medications like gabapentin or pregabalin. Apply it along the course of the decompressed nerves — along the inner ankle for tarsal tunnel release, along the outer knee for peroneal release.

Doctor Hoy’s also addresses the surgical site inflammation that persists during the weeks following the procedure. Post-surgical inflammation around the nerve tunnels can impede early nerve recovery by maintaining pressure on the healing tissues. Targeted topical anti-inflammatory therapy applied to the surgical areas (once incisions are fully closed, typically 2-3 weeks post-surgery) supports the local healing environment without the renal concerns associated with prolonged oral NSAID use in diabetic patients. This is particularly important because many neuropathy patients already have compromised kidney function from their diabetes.

DASS Compression Socks for Nerve Recovery Support

Optimal nerve regeneration requires adequate blood supply to deliver the oxygen and nutrients needed for axonal regrowth. Diabetic patients often have compromised lower extremity circulation, and post-surgical edema further reduces tissue perfusion around the decompressed nerve sites. DASS graduated compression socks with 20-30 mmHg of compression reduce postoperative swelling and support venous return, improving the local tissue environment for nerve healing. The graduated compression also helps prevent deep vein thrombosis during the reduced-mobility recovery period.

During the extended nerve regeneration phase (3-18 months post-surgery), consistent daily wear of DASS compression socks maintains the improved circulatory environment that supports ongoing nerve recovery. The reduced edema also decreases the external pressure on the decompressed nerve tunnels — swelling around the surgical site can create a new form of compression that undermines the surgical release if not controlled. For diabetic patients who already experience dependent edema from autonomic neuropathy, compression therapy provides benefits that extend well beyond the surgical recovery period.

Complete Post-Decompression Recovery Kit

Most Common Mistake After Nerve Decompression

Warning Signs After Nerve Decompression Surgery

Watch: Peripheral Neuropathy Treatment

https://www.youtube.com/watch?v=A11FFjCXAX4

Frequently Asked Questions About Nerve Decompression

Does nerve decompression cure diabetic neuropathy?

No. Nerve decompression does not cure the underlying metabolic nerve damage caused by diabetes. It addresses the superimposed mechanical compression that worsens symptoms in patients who have compression at identifiable anatomical sites. By relieving this mechanical component, the nerve can function at a higher level than with both metabolic and mechanical damage present. Ongoing glucose management remains essential for long-term nerve health.

How long does it take to see results from nerve decompression?

Pain improvement may begin within weeks as mechanical pressure is relieved. Sensory improvement typically begins at 3-6 months as nerve fibers regenerate at approximately 1mm per day. Meaningful recovery may continue for 18-24 months. Balance improvement follows a similar extended timeline. Setting realistic expectations about this gradual process is important for patient satisfaction and compliance with the postoperative program.

Who is a good candidate for nerve decompression surgery?

The ideal candidate has symptomatic diabetic neuropathy with a positive Tinel’s sign at one or more compression sites, documented neuropathy on nerve conduction studies, adequate blood supply (ABI above 0.7), no active ulceration, and the ability to comply with postoperative care. Patients with completely absent nerve responses may not benefit. Your surgeon will perform a thorough evaluation including nerve conduction studies to determine if you are a suitable candidate.

Is nerve decompression surgery covered by insurance?

Coverage varies by insurer and plan. Many insurance plans cover nerve decompression when medical necessity is documented with nerve conduction studies, clinical examination findings, and failure of conservative management. Medicare has covered the procedure for qualifying patients. Your surgeon’s office can verify coverage with your specific insurance plan before scheduling the procedure. Documentation of positive Tinel’s signs and abnormal electrodiagnostic studies strengthens the case for authorization.

Can nerve decompression prevent diabetic foot amputations?

Some studies suggest that restoring protective sensation through nerve decompression may reduce the risk of foot ulceration and subsequent amputation — since loss of protective sensation is the primary risk factor for diabetic foot ulcers. One study by Nickerson showed significantly lower ulcer and amputation rates in the decompression group compared to non-surgical controls. However, this has not been confirmed in large randomized trials. Even after successful decompression, diabetic foot protection practices should continue indefinitely.

Sources

1. Dellon AL. “Treatment of symptomatic diabetic neuropathy by surgical decompression of multiple peripheral nerves.” Plastic and Reconstructive Surgery. 1992;89(4):689-697.
2. Nickerson DS. “Low recurrence rate of diabetic foot ulcer after nerve decompression.” Journal of the American Podiatric Medical Association. 2010;100(2):111-115.
3. Upton AR, McComas AJ. “The double crush in nerve entrapment syndromes.” Lancet. 1973;2(7825):359-362.
4. Ducic I, et al. “A role for peripheral nerve surgery in the treatment of diabetic limb complications.” Microsurgery. 2015;35(5):339-344.
5. Macare van Maurik JF, et al. “”; “Surgical decompression of peripheral nerves for diabetic neuropathy: a systematic review.” Plastic and Reconstructive Surgery. 2014;134(2):325-332.

Schedule Your Neuropathy Evaluation

Related Neuropathy Resources

• Peripheral Neuropathy Treatment Options
• Complete Diabetic Foot Care Guide
• Podiatrist Recommended Foot Care Products 2026
• Tarsal Tunnel Syndrome Treatment

When to Consider Nerve Decompression for Diabetic Neuropathy

If you have diabetic peripheral neuropathy with documented nerve compression at known anatomic tunnels, surgical decompression may restore sensation and reduce pain. At Balance Foot & Ankle, we evaluate candidates for nerve decompression at our Howell and Bloomfield Hills offices.

Learn About Our Neuropathy Treatment Options | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Dellon AL. “Treatment of symptomatic diabetic neuropathy by surgical decompression of multiple peripheral nerves.” Plastic and Reconstructive Surgery. 1992;89(4):689-697.
2. Aszmann OC, Kress KM, Dellon AL. “Results of decompression of peripheral nerves in diabetics: a prospective, blinded study.” Plastic and Reconstructive Surgery. 2000;106(4):816-822.
3. Nickerson DS. “Low recurrence rate of diabetic foot ulcer after nerve decompression.” Journal of the American Podiatric Medical Association. 2010;100(2):111-115.

In-Office Treatment at Balance Foot & Ankle

If home treatment isn’t providing relief for your neuropathy, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.

Frequently Asked Questions

When should I see a podiatrist?

If symptoms persist past 2 weeks, affect your normal activity, or are accompanied by red-flag symptoms (warmth, redness, swelling, inability to bear weight).

What does treatment cost?

Most diagnostic visits and conservative treatments are covered by Medicare and major insurers. Out-of-pocket costs vary by your specific plan.

How quickly can I get an appointment?

Most non-urgent cases see us within 5 business days. Urgent cases (sudden pain, possible fracture) typically same or next business day.

What is Neuropathy?

Neuropathy is a common foot/ankle condition that affects mobility and quality of life. Understanding the underlying cause is the first step in successful treatment. Our podiatrists at Balance Foot & Ankle perform a hands-on biomechanical exam, review your activity history, and use diagnostic imaging when appropriate to identify the root cause—not just treat the symptom. Many patients have been told to “rest and ice” without a deeper diagnostic workup; our approach is different.

Symptoms and warning signs

Common signs of neuropathy include pain that worsens with activity, morning stiffness, swelling, tenderness when palpated, and difficulty bearing weight. If you experience sudden severe pain, inability to walk, visible deformity, numbness or color change, contact our office the same day or visit urgent care—these can signal a more serious injury such as a fracture, tendon rupture, or vascular compromise. Diabetics with any foot wound should seek same-day care.

Conservative treatment options

Most cases of neuropathy respond to non-surgical care: structured rest, supportive footwear changes, custom orthotics, targeted stretching and strengthening protocols, anti-inflammatory medications when medically appropriate, and in-office procedures such as ultrasound-guided injections. We also offer advanced therapies including MLS laser therapy, EPAT/shockwave, regenerative injections, and image-guided procedures. Treatment is sequenced from least invasive to most invasive, and we explain the rationale at every step.

When is surgery considered?

Surgery is reserved for cases that fail 3-6 months of well-structured conservative care, when there is structural pathology (severe deformity, complete tear, advanced arthritis), or when imaging shows damage that will not heal without intervention. Our surgeons have performed 3,000+ foot and ankle procedures and prioritize minimally-invasive techniques whenever appropriate. We discuss recovery timelines, return-to-activity milestones, and realistic outcome expectations before any procedure is scheduled.

American Podiatric Medical Association: Neuropathy

Recovery timeline and prevention

Recovery from neuropathy varies based on severity and chosen treatment path. Conservative cases often improve within 4-8 weeks with consistent adherence to the protocol. Post-procedural recovery may range from a few days (in-office procedures) to several months (reconstructive surgery). Long-term prevention involves footwear assessment, activity modification, structured strengthening, and regular check-ins with your podiatrist if you have a history of recurrence. We provide written home-exercise plans and digital follow-up support.